Study ID | Time | Area | No of medicines | Medicines availability | |||
Public hospitals | Private pharmacies | ||||||
OBs | LPGs | OBs | LPGs | ||||
Chen et al 20228 | 2021 | Sichuan Province, China | 30 | 9.7% | 46.5% | / | / |
Wang et al 202044 | 2019 | Weifang City, Shandong Province, China | 20 | 15.8% | 44.8% | 30.3% | 36.7% |
Dai et al 202045 | 2017 | China | 42 | 33.0% | 32.0% | / | / |
Wei et al 201946 | 2016 | China | 49 | 1.8% | 29.5% | / | / |
Wei et al 201946 | 2012 | China | 49 | 1.6% | 40.0% | / | / |
Sun et al 201847 | 2017 | Jiangsu Province, China | 40 | 7.5% | 34.2% | 8.9% | 29.4% |
Wang et al 201448 | 2012 | Shaanxi Province, China | 28 | 10.8% | 27.3% | 11.9% | 20.6% |
Note: Availability: the proportion(%) of public hospitals or private pharmacies that could provide medicines.
LPGs, lowest price generics; OBs, original brands.